GHW International provided earnings guidance for the year ended 31 December 2023. The Group expects to record a profit attributable to owners of the Company of approximately RMB 3 million for the Current Year, compared to a profit attributable to owners of the Company of approximately RMB 275 million for the year ended 31 December 2022. Based on the information currently available, the expected decrease in profit attributable to owners of the Company for the Current Year was mainly attributable to (i) a decrease in gross profit as a result of the decrease in gross profits generated from major products, including choline chloride, betaine, iodine and iodine derivatives; and (ii) an increase in administrative expenses due to increases in transportation expense and advisory fees for conducting feasibility studies of potential expansion plans and site visits of locations such as Malaysia, and safety and environmental expenses as a result of expanding product range, which is partially offset by the decrease in (i) selling and distribution expenses due to the significant decreases in shipment and logistics costs; and (ii) income tax expense, which was in line with the decrease in profit before taxation generated for the Current Year.